Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Declines By 10.4%
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Declines By 10.4%
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 12,000 shares, a decrease of 10.4% from the January 31st total of 13,400 shares. Based on an average daily trading volume, of 25,300 shares, the days-to-cover ratio is presently 0.5 days.
Alpha Tau Medical Ltd.（纳斯达克股票代码：DRTSW — Get Rating）是2月份空头利率大幅下降的目标。截至2月15日，空头利率共计12,000股，较1月31日的13,400股总额下降了10.4％。根据25,300股的平均每日交易量，目前的天数与覆盖率为0.5天。
Alpha Tau Medical Stock Performance
阿尔法泰医疗股票表现
Shares of NASDAQ:DRTSW traded up $0.01 during trading on Tuesday, reaching $0.40. 2,100 shares of the company traded hands, compared to its average volume of 18,657. Alpha Tau Medical has a 52 week low of $0.18 and a 52 week high of $1.06. The company's 50 day moving average is $0.38 and its two-hundred day moving average is $0.38.
纳斯达克股票代码：DRTSW的股价在周二的交易中上涨了0.01美元，达到0.40美元。该公司有2,100股交易，而平均交易量为18,657股。Alpha Tau Medical的52周低点为0.18美元，52周高点为1.06美元。该公司的50天移动平均线为0.38美元，其200天移动平均线为0.38美元。
Institutional Investors Weigh In On Alpha Tau Medical
机构投资者对 Alpha Tau Medical 加
Institutional investors and hedge funds have recently bought and sold shares of the company. Polar Asset Management Partners Inc. acquired a new position in shares of Alpha Tau Medical in the 1st quarter valued at approximately $134,000. Walleye Capital LLC bought a new position in Alpha Tau Medical in the first quarter valued at approximately $112,000. Whitebox Advisors LLC acquired a new position in Alpha Tau Medical during the third quarter valued at approximately $65,000. Chicago Partners Investment Group LLC bought a new stake in Alpha Tau Medical during the first quarter worth $55,000. Finally, Walleye Trading LLC acquired a new stake in shares of Alpha Tau Medical in the 1st quarter valued at $65,000.
机构投资者和对冲基金最近买入和卖出了该公司的股票。Polar Asset Management Partners Inc.在第一季度收购了Alpha Tau Medical的新股份，价值约13.4万美元Walleye Capital LLC在第一季度收购了Alpha Tau Medical的新头寸，价值约11.2万美元。Whitebox Advisors LLC在第三季度收购了Alpha Tau Medical的新职位，价值约为65,000美元。芝加哥合作伙伴投资集团有限责任公司在第一季度收购了Alpha Tau Medical的新股份，价值55,000美元。最后，Walleye Trading LLC在第一季度收购了Alpha Tau Medical的新股份，价值65,000美元。
Alpha Tau Medical Company Profile
Alpha Tau 医疗公司简介
(Get Rating)
（获取评分）
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.
Alpha Tau Medical Ltd. 是一家临床阶段的肿瘤治疗公司，在以色列和美国从事用于治疗实体癌的弥散α-发射体放射疗法（Alpha DarT）的研究、开发和商业化。其 Alpha-DART 技术用于皮肤癌、口腔癌、胰腺癌和乳腺癌的临床试验；以及肝细胞癌、肺癌和前列腺癌的临床前研究。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTSW)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets "Powelled": S&P 500 Confirms Resistance
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Rivian Plummets, But Is This 2023's Greatest Buying Opportunity?
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
- 免费获取 StockNews.com 关于 Alpha Tau Medical (DRTSW) 的研究报告的副本
- 雷达之下的 Azul SA 因强劲的旅行需求而起飞
- 市场变得 “强势”：标准普尔500指数确认阻力
- Ulta Insiders 坚持不懈：Sell-Siders 买入
- Rivian 暴跌，但这是 2023 年最大的买入机会吗？
- 潜在收益将Ambrx Biopharma评为适度买入
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Alpha Tau 医学日报的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Alpha Tau Medical及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。